These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6740070)

  • 1. Observations on the use of oral poliovirus vaccines in the Caribbean and Canada.
    Spence L
    Rev Infect Dis; 1984; 6 Suppl 2():S331-3. PubMed ID: 6740070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication of poliomyelitis in Cuba: a historical perspective.
    Más Lago P
    Bull World Health Organ; 1999; 77(8):681-7. PubMed ID: 10516790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.
    Ramsay ME; Begg NT; Gandhi J; Brown D
    Pediatr Infect Dis J; 1994 Dec; 13(12):1117-21. PubMed ID: 7892081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Observation on immunizing effect of live trivalent oral poliomyelitis vaccine].
    Hu XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1982 Sep; 16(5):285-9. PubMed ID: 7151589
    [No Abstract]   [Full Text] [Related]  

  • 6. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preventive poliomyelitis immunization].
    Böthig B
    Z Arztl Fortbild (Jena); 1990; 84(8):365-7. PubMed ID: 2165712
    [No Abstract]   [Full Text] [Related]  

  • 9. Monovalent oral poliovirus vaccines--a good tool but not a total solution.
    Ehrenfeld E; Chumakov K
    N Engl J Med; 2008 Oct; 359(16):1726-7. PubMed ID: 18923176
    [No Abstract]   [Full Text] [Related]  

  • 10. The humoral immune response to type 1 oral poliovirus vaccine in children previously immunized with enhanced potency inactivated poliovirus vaccine or live oral poliovirus vaccine.
    Modlin JF; Onorato IM; McBean AM; Albrecht P; Thoms ML; Nerhood L; Bernier R
    Am J Dis Child; 1990 Apr; 144(4):480-4. PubMed ID: 2157337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
    Chen RT; Hausinger S; Dajani AS; Hanfling M; Baughman AL; Pallansch MA; Patriarca PA
    JAMA; 1996 Jun; 275(21):1639-45. PubMed ID: 8637136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
    Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
    Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monovalent type 1 oral poliovirus vaccine in newborns.
    el-Sayed N; el-Gamal Y; Abbassy AA; Seoud I; Salama M; Kandeel A; Hossny E; Shawky A; Hussein HA; Pallansch MA; van der Avoort HG; Burton AH; Sreevatsava M; Malankar P; Wahdan MH; Sutter RW
    N Engl J Med; 2008 Oct; 359(16):1655-65. PubMed ID: 18923170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Revaccination by oral monovalent poliovaccine type 3 (author's transl)].
    Srámová H; Teplý V; Bernatziková V
    Cesk Epidemiol Mikrobiol Imunol; 1981 Mar; 30(2):95-100. PubMed ID: 6261973
    [No Abstract]   [Full Text] [Related]  

  • 16. Serological evaluation of poliomyelitis oral and inactivated vaccines in an urban low-income population at Rio de Janeiro, Brazil.
    Schatzmayr HG; Maurice Y; Fujita M; de Fillipis AM
    Vaccine; 1986 Jun; 4(2):111-3. PubMed ID: 3014770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial.
    Estívariz CF; Anand A; Gary HE; Rahman M; Islam J; Bari TI; Wassilak SG; Chu SY; Weldon WC; Pallansch MA; Heffelfinger JD; Luby SP; Zaman K
    Lancet Infect Dis; 2015 Aug; 15(8):898-904. PubMed ID: 26093980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines.
    J Infect Dis; 1997 Feb; 175 Suppl 1():S215-27. PubMed ID: 9203720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
    Cáceres VM; Sutter RW
    Clin Infect Dis; 2001 Aug; 33(4):531-41. PubMed ID: 11462191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman.
    Sutter RW; Suleiman AJ; Malankar PG; Mehta FR; Medany MA; Arif MA; Linkins RW; Pallansch MA; El-Bualy MS; Robertson SE
    J Infect Dis; 1997 Feb; 175 Suppl 1():S235-40. PubMed ID: 9203722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.